Phase I study of glasdegib (PF-04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies
一项针对日本特定血液系统恶性肿瘤患者的口服Smoothened抑制剂glasdegib(PF-04449913)的I期研究
期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.13285
Minami, Yosuke; Minami, Hironobu; Miyamoto, Toshihiro; Yoshimoto, Goichi; Kobayashi, Yukio; Munakata, Wataru; Onishi, Yasushi; Kobayashi, Masahiro; Ikuta, Mari; Chan, Geoffrey; Woolfson, Adrian; Ono, Chiho; Shaik, Mohammed Naveed; Fujii, Yosuke; Zheng, Xianxian; Naoe, Tomoki